A spokesman for the Corona National Headquarters denied that the Sinofarm vaccine had been removed from the country’s vaccination basket; An issue that was announced in the media a few hours ago by the chairman of the National Committee of Corona Epidemiology and said that if the results of studies show that the Sinofarm vaccines used in the country are of low quality, decisions may be made to remove this vaccine from the vaccination basket.
Although more than three quarters of the imported corona vaccine is Sinofarm and most of the people of our country received this vaccine; However, there are speculations that this vaccine is less immunogenic than other vaccines. Some media outlets reported that Sinofarm vaccines imported to Iran were of low quality.
Speaking to Rokna News Agency, the head of the National Committee for Epidemiology of Corona spoke about this claim and said that “a comprehensive study should be done on a high statistical population of people who have been vaccinated with Sinofarm and their antibody levels should be determined.” » He stressed that there is no evidence that the Sinofarm vaccines imported into the country are of poor quality: “If studies show that the Sinofarm vaccines used are of poor quality, decisions may be made about removing the vaccine from the country’s vaccination basket.”
After the comments were made in the media, the spokesman of the National Corona Headquarters, in a conversation with Hamshahri, while denying this issue, stated that Sinofarm Vaccine is approved by the Food and Drug Administration of Iran, which also has a global license for emergency use: “Its effectiveness has been studied.” “Studies of different effects on vaccines show that Sinofarm has been shown to be effective in building immunity:” It should be noted that vaccines are a means of preventing disease, but protocols should still be observed. Accordingly, we have no plans to change or remove Sinofarm from the country’s vaccination portfolio. “In particular, all vaccines imported into the country have been approved by the Food and Drug Administration.”
According to the spokesman of the National Corona Headquarters, 67% of the country has been vaccinated with Sinofarm and the positive effects of this vaccine, especially in the elderly, have been proven in the fifth peak: “The reduction in hospitalization and mortality, especially among the elderly, is significant compared to previous peaks.”
It should be noted that none of the manufacturers of corona vaccines have claimed that their vaccines completely prevent death from coronary heart disease. But Reisi believes that vaccination in any situation “certainly outweighs the many benefits of general vaccination and its many disadvantages.”
It should be noted that the World Health Organization approved 1,400 Chinese Sinofarm vaccines on May 6, and issued an emergency permit to use them.